French drugmaker Sanofi is battling development delays against COVID-19 with its own vaccine candidates, switching more of its production facilities to industrial competitors, teaming up with Johnson & Johnson to make millions of its rival Conovirus vaccines Produces supplements.

Johnson & Johnson is the second competitor to make a deal with Sanofi to use its facilities, an unusual collaboration for a competitive industry that now faces intense pressure from governments to speed up the production of vaccines against the devastating global epidemic Has been doing.

Sanofi’s CEO, Paul Hudson, said the agreement announced Monday by the company “demonstrates its commitment to a collective effort to end this crisis as quickly as possible.”

Sanofi is still prioritizing the development of two of its coronavirus virus vaccine programs, Hudson said in a company statement.

South Africa coronaryvus variants detected in New York resident

But “where we have the right manufacturing capabilities, we are moving forward to show solidarity in the industry and continue to do our part in the fight against COVID-19,” he said.

Sanofi said it would build its Marcy L’Tile vaccine manufacturing plant near the city of Leon and fill vials of single-dose vaccines for Johnson & Johnson’s Johnson companies.

American Coroneth Death TOLL APPROACHES 500,000

Sanofi will mix together the vaccine material sent by Janssen and fill the vials, and then send the entire vials back to Janssen for packaging. The French plant is expected to produce around 12 million doses per month, starting in the second half of this year.

Sanofi had Already announced Frankfurt will also help package 125 million vaccine supplements for its facilities in Germany, Bottle and Pfizer-BioNTech’s rival partnership.

Click here for complete coronary coverage

The latest announcement by Sanofi was promptly removed by French President Emmanuel Macron. Due to the high global demand and supply problems of the vaccine, his government has pressed Sanofi to use its facilities to help it produce vaccines from its rivals.

Macron tweeted, “We should accelerate the production of vaccines with an industrial partnership together.”